本頁面由Tiger Trade Technology Pte. Ltd.提供服務

OnKure Therapeutics, Inc.

3.10
-0.1700-5.20%
盤後3.100.00000.00%19:30 EDT
成交量:25.36萬
成交額:78.90萬
市值:1.25億
市盈率:-0.89
高:3.33
開:3.31
低:2.98
收:3.27
52周最高:5.38
52周最低:2.23
股本:4,039.55萬
流通股本:3,696.94萬
量比:1.92
換手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-3.4954
每股收益(LYR):-4.4035
淨資產收益率:-46.91%
總資產收益率:-29.26%
市淨率:0.73
市盈率(LYR):-0.70

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/10

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/06/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/27

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/01

SEC問詢函

Form CORRESP - Correspondence
2026/04/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans